46 | | - | qqqq. U-47109. 35 |
---|
47 | | - | rrrr. U-48520. 36 General Assembly Of North Carolina Session 2025 |
---|
48 | | - | Page 2 House Bill 330-Second Edition |
---|
49 | | - | ssss. N,N-didesmethyl U-47700. 1 |
---|
50 | | - | tttt. U-62066. 2 |
---|
51 | | - | uuuu. Propyl U-47700. 3 |
---|
52 | | - | vvvv. (2,3- or 3,4)-Ethylenedioxy U-51754. 4 |
---|
53 | | - | wwww. 4-phenyl U-51754. 5 |
---|
54 | | - | xxxx. N-desmethyl U-47700. 6 |
---|
55 | | - | yyyy. (2,3- or 3,4)-Ethylenedioxy U-47700. 7 |
---|
56 | | - | zzzz. N-methyl U-47931E. 8 |
---|
57 | | - | aaaaa. (2,3- or 3,4)-Methylenedioxy U-47700. 9 |
---|
58 | | - | bbbbb. U-69593. 10 |
---|
59 | | - | ccccc. U-50488. 11 |
---|
60 | | - | ddddd. U-48753E. 12 |
---|
61 | | - | eeeee. U-47931E." 13 |
---|
62 | | - | SECTION 1.(b) G.S. 90-89(1a) reads as rewritten: 14 |
---|
63 | | - | "(1a) Fentanyl derivatives. – Unless specifically excepted, listed in another 15 |
---|
64 | | - | schedule, or contained within a pharmaceutical product approved by the 16 |
---|
65 | | - | United States Food and Drug Administration, any compound structurally 17 |
---|
66 | | - | derived from N-[1-(2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide 18 |
---|
67 | | - | (Fentanyl) by any substitution on or replacement of the phenethyl group, any 19 |
---|
68 | | - | substitution on the piperidine ring, any substitution on or replacement of the 20 |
---|
69 | | - | propanamide group, any substitution on the anilido phenyl group, or any 21 |
---|
70 | | - | combination of the above unless specifically excepted or listed in another 22 |
---|
71 | | - | schedule to include their salts, isomers, and salts of isomers. Fentanyl 23 |
---|
72 | | - | derivatives include, but are not limited to, the following: 24 |
---|
| 47 | + | qqqq. U-47109. 35 General Assembly Of North Carolina Session 2025 |
---|
| 48 | + | Page 2 House Bill 330-First Edition |
---|
| 49 | + | rrrr. U-48520. 1 |
---|
| 50 | + | ssss. N,N-didesmethyl U-47700. 2 |
---|
| 51 | + | tttt. U-62066. 3 |
---|
| 52 | + | uuuu. Propyl U-47700. 4 |
---|
| 53 | + | vvvv. (2,3- or 3,4)-Ethylenedioxy U-51754. 5 |
---|
| 54 | + | wwww. 4-phenyl U-51754. 6 |
---|
| 55 | + | xxxx. N-desmethyl U-47700. 7 |
---|
| 56 | + | yyyy. (2,3- or 3,4)-Ethylenedioxy U-47700. 8 |
---|
| 57 | + | zzzz. N-methyl U-47931E. 9 |
---|
| 58 | + | aaaaa. (2,3- or 3,4)-Methylenedioxy U-47700. 10 |
---|
| 59 | + | bbbbb. U-69593. 11 |
---|
| 60 | + | ccccc. U-50488. 12 |
---|
| 61 | + | ddddd. U-48753E. 13 |
---|
| 62 | + | eeeee. U-47931E." 14 |
---|
| 63 | + | SECTION 1.(b) G.S. 90-89(1a) reads as rewritten: 15 |
---|
| 64 | + | "(1a) Fentanyl derivatives. – Unless specifically excepted, listed in another 16 |
---|
| 65 | + | schedule, or contained within a pharmaceutical product approved by the 17 |
---|
| 66 | + | United States Food and Drug Administration, any compound structurally 18 |
---|
| 67 | + | derived from N-[1-(2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide 19 |
---|
| 68 | + | (Fentanyl) by any substitution on or replacement of the phenethyl group, any 20 |
---|
| 69 | + | substitution on the piperidine ring, any substitution on or replacement of the 21 |
---|
| 70 | + | propanamide group, any substitution on the anilido phenyl group, or any 22 |
---|
| 71 | + | combination of the above unless specifically excepted or listed in another 23 |
---|
| 72 | + | schedule to include their salts, isomers, and salts of isomers. Fentanyl 24 |
---|
| 73 | + | derivatives include, but are not limited to, the following: 25 |
---|
| 74 | + | … 26 |
---|
| 75 | + | f.27 |
---|
| 76 | + | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana28 |
---|
| 77 | + | mide (also known as 2-fluorofentanyl).(also known as 29 |
---|
| 78 | + | ortho-fluorofentanyl). 30 |
---|
| 79 | + | g.31 |
---|
| 80 | + | N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana32 |
---|
| 81 | + | mide (also known as 3-fluorofentanyl).(also known as 33 |
---|
| 82 | + | meta-fluorofentanyl). 34 |
---|
| 83 | + | … 35 |
---|
| 84 | + | i.36 |
---|
| 85 | + | N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]37 |
---|
| 86 | + | -propanamide (also known as 4-fluoroisobutyryl fentanyl, 38 |
---|
| 87 | + | 4-FIBF).(also known as 4-fluoroisobutyryl fentanyl). 39 |
---|
| 88 | + | j. N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide 40 |
---|
| 89 | + | (also known as 4-fluorobutyryl fentanyl, 4-FBF).(also known as 41 |
---|
| 90 | + | 4-fluorobutyryl fentanyl)." 42 |
---|
| 91 | + | SECTION 1.(c) G.S. 90-89 is amended by adding a new subdivision to read: 43 |
---|
| 92 | + | "(1b) Nitazene derivatives. – The N-substituted benzimidazole structural class, 44 |
---|
| 93 | + | including any of the following derivatives, their salts, isomers, or salts of 45 |
---|
| 94 | + | isomers unless specifically utilized as part of the manufacturing process by a 46 |
---|
| 95 | + | commercial industry of a substance or material not intended for human 47 |
---|
| 96 | + | ingestion or consumption, as a prescription administered under medical 48 |
---|
| 97 | + | supervision, or for research at a recognized institution, whenever the existence 49 |
---|
| 98 | + | of these salts, isomers, or salts of isomers is possible within the specific 50 |
---|
| 99 | + | chemical designation or unless specifically excepted or listed in this or another 51 General Assembly Of North Carolina Session 2025 |
---|
| 100 | + | House Bill 330-First Edition Page 3 |
---|
| 101 | + | schedule, structurally derived from benzimidazole by substitution at the 1 |
---|
| 102 | + | 1-position nitrogen with an ethylamine group, and by substitution at the 2 |
---|
| 103 | + | 2-position carbon with a benzyl group, whether or not the compound is further 3 |
---|
| 104 | + | modified in any of the following ways: 4 |
---|
| 105 | + | a. By monoalkyl or dialkyl substitution on the 1'-nitrogen of the 5 |
---|
| 106 | + | 1-position ethylamine group, or by inclusion of the nitrogen in a cyclic 6 |
---|
| 107 | + | structure. 7 |
---|
| 108 | + | b. By substitution on the 2'-methylene carbon of the benzyl group by 8 |
---|
| 109 | + | alkyl or carboxamide groups. 9 |
---|
| 110 | + | c. By replacement of the 2'-methylene carbon group with an ethylbenzyl, 10 |
---|
| 111 | + | thiophenol, or methoxybenzene group, which may be further 11 |
---|
| 112 | + | substituted with alkyl, hydroxyl, alkoxy, acetoxy, halide, or sulfide 12 |
---|
| 113 | + | groups. 13 |
---|
| 114 | + | d. By substitution at the 2'-position, 3'-position, or 4'-position of the 14 |
---|
| 115 | + | benzyl group, or both, with alkyl, hydroxyl, alkoxy, acetoxy, halide, 15 |
---|
| 116 | + | or sulfide groups. 16 |
---|
| 117 | + | e. By replacement of a phenyl hydrogen atom at either the 5-position or 17 |
---|
| 118 | + | 6-position of the benzimidazole core with a nitro, or primary amine 18 |
---|
| 119 | + | group." 19 |
---|
| 120 | + | SECTION 1.(d) G.S. 90-89(3)mm. reads as rewritten: 20 |
---|
| 121 | + | "mm. 5-methoxy-N-methyl-N-propyltryptamine 21 |
---|
| 122 | + | (5-MeO-MiPT).5-methoxy-N-methyl-N-isopropyltryptamine 22 |
---|
| 123 | + | (5-MeO-MiPT)." 23 |
---|
| 124 | + | SECTION 1.(e) G.S. 90-89(4) is amended by adding a new sub-subdivision to read: 24 |
---|
| 125 | + | "j. Bromazolam." 25 |
---|
| 126 | + | SECTION 1.(f) G.S. 90-89(5)j. reads as rewritten: 26 |
---|
| 127 | + | "j. Substituted cathinones. A compound, other than bupropion, that is 27 |
---|
| 128 | + | structurally derived from 2-amino-1-phenyl-1-propanone by 28 |
---|
| 129 | + | modification in any of the following ways: (i) by substitution in the 29 |
---|
| 130 | + | phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, 30 |
---|
| 131 | + | or halide substituents, whether or not further substituted in the phenyl 31 |
---|
| 132 | + | ring by one or more other univalent substituents; (ii) by substitution at 32 |
---|
| 133 | + | the 3-position to any extent; or (iii) by substitution at the nitrogen atom 33 |
---|
| 134 | + | with alkyl, dialkyl, benzyl, cycloalkyl, or methoxybenzyl groups or by 34 |
---|
| 135 | + | inclusion of the nitrogen atom in a cyclic structure. For the purpose of 35 |
---|
| 136 | + | this paragraph, the term "isomer" includes the optical, positional, or 36 |
---|
| 137 | + | geometric isomer." 37 |
---|
| 138 | + | SECTION 1.(g) G.S. 90-89(7) reads as rewritten: 38 |
---|
| 139 | + | "(7) Synthetic cannabinoids. – Any quantity of any synthetic chemical compound 39 |
---|
| 140 | + | that (i) is a cannabinoid receptor agonist and mimics the pharmacological 40 |
---|
| 141 | + | effect of naturally occurring substances or (ii) has a stimulant, depressant, or 41 |
---|
| 142 | + | hallucinogenic effect on the central nervous system that is not listed as a 42 |
---|
| 143 | + | controlled substance in Schedules I through V, and is not an FDA-approved 43 |
---|
| 144 | + | drug. Synthetic cannabinoids include, but are not limited to, the substances 44 |
---|
| 145 | + | listed in sub-subdivisions a. through p. v. of this subdivision and any substance 45 |
---|
| 146 | + | that contains any quantity of their salts, isomers (whether optical, positional, 46 |
---|
| 147 | + | or geometric), homologues, and salts of isomers and homologues, unless 47 |
---|
| 148 | + | specifically excepted, whenever the existence of these salts, isomers, 48 |
---|
| 149 | + | homologues, and salts of isomers and homologues is possible within the 49 |
---|
| 150 | + | specific chemical designation. The following substances are examples of 50 General Assembly Of North Carolina Session 2025 |
---|
| 151 | + | Page 4 House Bill 330-First Edition |
---|
| 152 | + | synthetic cannabinoids and are not intended to be inclusive of the substances 1 |
---|
| 153 | + | included in this Schedule: 2 |
---|
| 154 | + | … 3 |
---|
| 155 | + | l. Indole carboxamides. Any compound structurally derived from 4 |
---|
| 156 | + | 1H-indole-3-carboxamide or 1H-indole-2-carboxamide substituted in 5 |
---|
| 157 | + | one or both of the following ways: 6 |
---|
| 158 | + | 1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 7 |
---|
| 159 | + | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 8 |
---|
| 160 | + | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 9 |
---|
| 161 | + | 1-(N-methyl-2-pyrrolidinyl)methyl, 10 |
---|
| 162 | + | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 11 |
---|
| 163 | + | benzyl, or halo benzyl group; andor 12 |
---|
| 164 | + | 2. At the nitrogen of the carboxamide by a phenyl, benzyl, 13 |
---|
| 165 | + | naphthyl, adamantyl, cyclopropyl, or propionaldehyde 14 |
---|
| 166 | + | group;group, or methyl 3,3-dimethyl-butanoate group; 15 |
---|
| 167 | + | whether or not the compound is further modified to any extent 16 |
---|
| 168 | + | in the following ways: (i) substitution to the indole ring to any 17 |
---|
| 169 | + | extent, (ii) substitution to the phenyl, benzyl, naphthyl, 18 |
---|
| 170 | + | adamantyl, cyclopropyl, or propionaldehyde group to any 19 |
---|
| 171 | + | extent, (iii) a nitrogen heterocyclic analog of the indole ring, or 20 |
---|
| 172 | + | (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 21 |
---|
| 173 | + | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 22 |
---|
| 174 | + | class include, but are not limited to: SDB-001 and 23 |
---|
| 175 | + | STS-135.STS-135 and MDMB-ICA. 24 |
---|
74 | | - | f.26 |
---|
75 | | - | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana27 |
---|
76 | | - | mide (also known as 2-fluorofentanyl).(also known as 28 |
---|
77 | | - | ortho-fluorofentanyl). 29 |
---|
78 | | - | g.30 |
---|
79 | | - | N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana31 |
---|
80 | | - | mide (also known as 3-fluorofentanyl).(also known as 32 |
---|
81 | | - | meta-fluorofentanyl). 33 |
---|
82 | | - | … 34 |
---|
83 | | - | i.35 |
---|
84 | | - | N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]36 |
---|
85 | | - | -propanamide (also known as 4-fluoroisobutyryl fentanyl, 37 |
---|
86 | | - | 4-FIBF).(also known as 4-fluoroisobutyryl fentanyl). 38 |
---|
87 | | - | j. N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide 39 |
---|
88 | | - | (also known as 4-fluorobutyryl fentanyl, 4-FBF).(also known as 40 |
---|
89 | | - | para-fluorobutyryl fentanyl)." 41 |
---|
90 | | - | SECTION 1.(c) G.S. 90-89 is amended by adding a new subdivision to read: 42 |
---|
91 | | - | "(1b) Nitazene derivatives. – The N-substituted benzimidazole structural class, 43 |
---|
92 | | - | including any of the following derivatives, their salts, isomers, or salts of 44 |
---|
93 | | - | isomers unless specifically utilized as part of the manufacturing process by a 45 |
---|
94 | | - | commercial industry of a substance or material not intended for human 46 |
---|
95 | | - | ingestion or consumption, as a prescription administered under medical 47 |
---|
96 | | - | supervision, or for research at a recognized institution, whenever the existence 48 |
---|
97 | | - | of these salts, isomers, or salts of isomers is possible within the specific 49 |
---|
98 | | - | chemical designation or unless specifically excepted or listed in this or another 50 |
---|
99 | | - | schedule, structurally derived from benzimidazole by substitution at the 51 General Assembly Of North Carolina Session 2025 |
---|
100 | | - | House Bill 330-Second Edition Page 3 |
---|
101 | | - | 1-position nitrogen with an ethylamine group, and by substitution at the 1 |
---|
102 | | - | 2-position carbon with a benzyl group, whether or not the compound is further 2 |
---|
103 | | - | modified in any of the following ways: 3 |
---|
104 | | - | a. By monoalkyl or dialkyl substitution on the 1'-nitrogen of the 4 |
---|
105 | | - | 1-position ethylamine group, or by inclusion of the nitrogen in a cyclic 5 |
---|
106 | | - | structure. 6 |
---|
107 | | - | b. By substitution on the 2'-methylene carbon of the benzyl group by 7 |
---|
108 | | - | alkyl or carboxamide groups. 8 |
---|
109 | | - | c. By replacement of the 2'-methylene carbon group with an ethylbenzyl, 9 |
---|
110 | | - | thiophenol, or methoxybenzene group, which may be further 10 |
---|
111 | | - | substituted with alkyl, hydroxyl, alkoxy, acetoxy, halide, or sulfide 11 |
---|
112 | | - | groups. 12 |
---|
113 | | - | d. By substitution at the 2'-position, 3'-position, or 4'-position of the 13 |
---|
114 | | - | benzyl group, or both, with alkyl, hydroxyl, alkoxy, acetoxy, halide, 14 |
---|
115 | | - | or sulfide groups. 15 |
---|
116 | | - | e. By replacement of a phenyl hydrogen atom at either the 5-position or 16 |
---|
117 | | - | 6-position of the benzimidazole core with a nitro, or primary amine 17 |
---|
118 | | - | group." 18 |
---|
119 | | - | SECTION 1.(d) G.S. 90-89(3)mm. reads as rewritten: 19 |
---|
120 | | - | "mm. 5-methoxy-N-methyl-N-propyltryptamine 20 |
---|
121 | | - | (5-MeO-MiPT).5-methoxy-N-methyl-N-isopropyltryptamine 21 |
---|
122 | | - | (5-MeO-MiPT)." 22 |
---|
123 | | - | SECTION 1.(e) G.S. 90-89(4) is amended by adding a new sub-subdivision to read: 23 |
---|
124 | | - | "j. Bromazolam." 24 |
---|
125 | | - | SECTION 1.(f) G.S. 90-89(5)j. reads as rewritten: 25 |
---|
126 | | - | "j. Substituted cathinones. A compound, other than bupropion, that is 26 |
---|
127 | | - | structurally derived from 2-amino-1-phenyl-1-propanone by 27 |
---|
128 | | - | modification in any of the following ways: (i) by substitution in the 28 |
---|
129 | | - | phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, 29 |
---|
130 | | - | or halide substituents, whether or not further substituted in the phenyl 30 |
---|
131 | | - | ring by one or more other univalent substituents; (ii) by substitution at 31 |
---|
132 | | - | the 3-position to any extent; or (iii) by substitution at the nitrogen atom 32 |
---|
133 | | - | with alkyl, dialkyl, benzyl, cycloalkyl, or methoxybenzyl groups or by 33 |
---|
134 | | - | inclusion of the nitrogen atom in a cyclic structure. For the purpose of 34 |
---|
135 | | - | this paragraph, the term "isomer" includes the optical, positional, or 35 |
---|
136 | | - | geometric isomer." 36 |
---|
137 | | - | SECTION 1.(g) G.S. 90-89(7) reads as rewritten: 37 |
---|
138 | | - | "(7) Synthetic cannabinoids. – Any quantity of any synthetic chemical compound 38 |
---|
139 | | - | that (i) is a cannabinoid receptor agonist and mimics the pharmacological 39 |
---|
140 | | - | effect of naturally occurring substances or (ii) has a stimulant, depressant, or 40 |
---|
141 | | - | hallucinogenic effect on the central nervous system that is not listed as a 41 |
---|
142 | | - | controlled substance in Schedules I through V, and is not an FDA-approved 42 |
---|
143 | | - | drug. Synthetic cannabinoids include, but are not limited to, the substances 43 |
---|
144 | | - | listed in sub-subdivisions a. through p. v. of this subdivision and any substance 44 |
---|
145 | | - | that contains any quantity of their salts, isomers (whether optical, positional, 45 |
---|
146 | | - | or geometric), homologues, and salts of isomers and homologues, unless 46 |
---|
147 | | - | specifically excepted, whenever the existence of these salts, isomers, 47 |
---|
148 | | - | homologues, and salts of isomers and homologues is possible within the 48 |
---|
149 | | - | specific chemical designation. The following substances are examples of 49 |
---|
150 | | - | synthetic cannabinoids and are not intended to be inclusive of the substances 50 |
---|
151 | | - | included in this Schedule: 51 General Assembly Of North Carolina Session 2025 |
---|
152 | | - | Page 4 House Bill 330-Second Edition |
---|
153 | | - | … 1 |
---|
154 | | - | l. Indole carboxamides. Any compound structurally derived from 2 |
---|
155 | | - | 1H-indole-3-carboxamide or 1H-indole-2-carboxamide substituted in 3 |
---|
156 | | - | one or both of the following ways: 4 |
---|
157 | | - | 1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 5 |
---|
158 | | - | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 6 |
---|
159 | | - | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 7 |
---|
160 | | - | 1-(N-methyl-2-pyrrolidinyl)methyl, 8 |
---|
161 | | - | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 9 |
---|
162 | | - | benzyl, or halo benzyl group; andor 10 |
---|
163 | | - | 2. At the nitrogen of the carboxamide by a phenyl, benzyl, 11 |
---|
164 | | - | naphthyl, adamantyl, cyclopropyl, or propionaldehyde 12 |
---|
165 | | - | group;group, or methyl 3,3-dimethyl-butanoate group; 13 |
---|
166 | | - | whether or not the compound is further modified to any extent 14 |
---|
167 | | - | in the following ways: (i) substitution to the indole ring to any 15 |
---|
168 | | - | extent, (ii) substitution to the phenyl, benzyl, naphthyl, 16 |
---|
169 | | - | adamantyl, cyclopropyl, or propionaldehyde group to any 17 |
---|
170 | | - | extent, (iii) a nitrogen heterocyclic analog of the indole ring, or 18 |
---|
171 | | - | (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 19 |
---|
172 | | - | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 20 |
---|
173 | | - | class include, but are not limited to: SDB-001 and 21 |
---|
174 | | - | STS-135.STS-135 and MDMB-ICA. 22 |
---|
175 | | - | … 23 |
---|
176 | | - | n. Indazole carboxaldehydes. Any compound structurally derived from 24 |
---|
177 | | - | 1H-indazole-3-carboxaldehyde or 1H-indazole-2-carboxaldehyde 25 |
---|
178 | | - | substituted in both of the following ways: 26 |
---|
179 | | - | … 27 |
---|
180 | | - | 2. At the carbon of the carboxaldehyde by a phenyl, benzyl, 28 |
---|
181 | | - | naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 29 |
---|
182 | | - | whether or not the compound is further modified to any extent 30 |
---|
183 | | - | in the following ways: (i) substitution to the indazole ring to 31 |
---|
184 | | - | any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 32 |
---|
185 | | - | adamantyl, cyclopropyl, or propionaldehyde group to any 33 |
---|
186 | | - | extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 34 |
---|
187 | | - | or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 35 |
---|
188 | | - | naphthyl, adamantyl, or cyclopropyl ring. 36 |
---|
189 | | - | o. Indazole carboxamides. Any compound structurally derived from 37 |
---|
190 | | - | 1H-indazole-3-carboxamide or 1H -indazole-2-carboxamide 38 |
---|
191 | | - | substituted in one or both of the following ways: 39 |
---|
192 | | - | 1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 40 |
---|
193 | | - | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 41 |
---|
194 | | - | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 42 |
---|
195 | | - | 1-(N-methyl-2-pyrrolidinyl)methyl, 43 |
---|
196 | | - | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 44 |
---|
197 | | - | benzyl, or halo benzyl group; andor 45 |
---|
198 | | - | 2. At the nitrogen of the carboxamide by a phenyl, benzyl, 46 |
---|
199 | | - | naphthyl, adamantyl, cyclopropyl, or propionaldehyde 47 |
---|
200 | | - | group;group, or methyl 3,3-dimethyl-butanoate group; 48 |
---|
201 | | - | whether or not the compound is further modified to any extent in the 49 |
---|
202 | | - | following ways: (i) substitution to the indazole ring to any extent, (ii) 50 |
---|
203 | | - | substitution to the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, 51 General Assembly Of North Carolina Session 2025 |
---|
204 | | - | House Bill 330-Second Edition Page 5 |
---|
205 | | - | or propionaldehyde group to any extent, (iii) a nitrogen heterocyclic 1 |
---|
206 | | - | analog of the indazole ring, or (iv) a nitrogen heterocyclic analog of 2 |
---|
207 | | - | the phenyl, benzyl, naphthyl, adamantyl, or cyclopropyl ring. 3 |
---|
208 | | - | Substances in this class include, but are not limited to: AKB-48, 4 |
---|
209 | | - | fluoro-AKB-48, APINCACA, AB-PINACA, AB-FUBINACA, 5 |
---|
210 | | - | ADB-FUBINACA, and ADB-PINACA.ADB-PINACA, 6 |
---|
211 | | - | ADB-INACA, MDMB -INACA, MDMB -5Me-INACA, and 7 |
---|
212 | | - | MDMB-5Br-INACA. 8 |
---|
213 | | - | … 9 |
---|
214 | | - | s. Oxindoles. Any compound structurally derived from 10 |
---|
215 | | - | 3-hydrazonoindolin-2-one substituted in one or both of the following 11 |
---|
216 | | - | ways: 12 |
---|
217 | | - | 1. At the nitrogen atom of the oxoindole ring by an alkyl, 13 |
---|
218 | | - | haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, 14 |
---|
219 | | - | cycloalkylethyl; or 15 |
---|
220 | | - | 2. At the nitrogen of the hydrazide by a phenyl, benzyl, naphthyl, 16 |
---|
221 | | - | adamantyl, cyclopropyl, or propionaldehyde group; 17 |
---|
222 | | - | whether or not the compound is further modified to any extent 18 |
---|
223 | | - | in the following ways: (i) substitution to the oxoindole ring to 19 |
---|
224 | | - | any extent or (ii) substitution to the phenyl, benzyl, naphthyl, 20 |
---|
225 | | - | adamantyl, cyclopropyl, or propionaldehyde group to any 21 |
---|
226 | | - | extent. Substances in this class include, but are not limited to: 22 |
---|
227 | | - | BZO-POXIZID, BZO-HEXOXIZIDE, 5F-BZO-POXIZIDE. 23 |
---|
228 | | - | t. Indole acetamides. Any compound structurally derived from 24 |
---|
229 | | - | 1H-indole-3-acetamide or 1H-indole-2-acetamide substituted in one or 25 |
---|
230 | | - | both of the following ways: 26 |
---|
231 | | - | 1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 27 |
---|
232 | | - | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 28 |
---|
233 | | - | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 29 |
---|
234 | | - | 1-(N-methyl-2-pyrrolidinyl)methyl, 30 |
---|
235 | | - | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 31 |
---|
236 | | - | benzyl, or halo benzyl group; or 32 |
---|
237 | | - | 2. At the nitrogen of the acetamide by a phenyl, benzyl, naphthyl, 33 |
---|
238 | | - | adamantyl, cyclopropyl, or propionaldehyde group; 34 |
---|
239 | | - | whether or not the compound is further modified to any extent 35 |
---|
240 | | - | in the following ways: (i) substitution to the indole ring to any 36 |
---|
241 | | - | extent, (ii) substitution to the phenyl, benzyl, naphthyl, 37 |
---|
242 | | - | adamantyl, cyclopropyl, or propionaldehyde group to any 38 |
---|
243 | | - | extent, (iii) a nitrogen heterocyclic analog of the indole ring, or 39 |
---|
244 | | - | (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 40 |
---|
245 | | - | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 41 |
---|
246 | | - | class include, but are not limited to: AFUBIATA, CH-PIATA, 42 |
---|
247 | | - | AB-CHMIATA, ADB-FUBIATA. 43 |
---|
248 | | - | u. Indazole acetaldehydes. Any compound structurally derived from 44 |
---|
249 | | - | 1H-indazol-3-ylacetaldehyde or 1H-indazol-2-ylacetaldehyde 45 |
---|
250 | | - | substituted in one or both of the following ways: 46 |
---|
251 | | - | 1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 47 |
---|
252 | | - | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 48 |
---|
253 | | - | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 49 |
---|
254 | | - | 1-(N-methyl-2-pyrrolidinyl)methyl, 50 General Assembly Of North Carolina Session 2025 |
---|
255 | | - | Page 6 House Bill 330-Second Edition |
---|
256 | | - | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 1 |
---|
257 | | - | benzyl, or halo benzyl group; or 2 |
---|
258 | | - | 2. At the nitrogen of the carboxamide by a phenyl, benzyl, 3 |
---|
259 | | - | naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 4 |
---|
260 | | - | whether or not the compound is further modified to any extent 5 |
---|
261 | | - | in the following ways: (i) substitution to the indazole ring to 6 |
---|
262 | | - | any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 7 |
---|
263 | | - | adamantyl, cyclopropyl, or propionaldehyde group to any 8 |
---|
264 | | - | extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 9 |
---|
265 | | - | or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 10 |
---|
266 | | - | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 11 |
---|
267 | | - | class include, but are not limited to: ADB-BUTINAATA, 12 |
---|
268 | | - | ADB-FUBINAATA. 13 |
---|
269 | | - | v. Pyrazoles. Any compound structurally derived from 1H-pyrazole 14 |
---|
270 | | - | substituted in all of the following ways: 15 |
---|
271 | | - | 1. At the 1 position of the pyrazole ring by an alkyl, haloalkyl, or 16 |
---|
272 | | - | alkenyl group. 17 |
---|
273 | | - | 2. At the 3 position of the pyrazole ring by a halo benzyl or 18 |
---|
274 | | - | propionaldehyde group. 19 |
---|
275 | | - | 3. At the 5 position of the pyrazole ring by a halo benzyl or 20 |
---|
276 | | - | propionaldehyde group; 21 |
---|
277 | | - | whether or not the compound is further modified by a 22 |
---|
278 | | - | substitution to the propionaldehyde group to any extent. 23 |
---|
279 | | - | Substances in this class include, but are not limited to: 24 |
---|
280 | | - | 3,5-ADB-4en-PFUPPYCA, 5-fluoro-3,5-AB-PFUPPYCA." 25 |
---|
281 | | - | SECTION 1.(h) G.S. 90-90(2)h1. reads as rewritten: 26 |
---|
282 | | - | "h1. Fentanyl immediate pr ecursor chemical, 27 |
---|
283 | | - | 4-anilino-N-phenethyl-4-piperidine 28 |
---|
284 | | - | (ANPP).4-anilino-N-phenethylpiperdine (ANPP)." 29 |
---|
285 | | - | SECTION 1.(i) G.S. 90-91(k)11. reads as rewritten: 30 |
---|
286 | | - | "11. Dehydrochlormethyltestosterone,Dehydrochloromethyltestosterone," 31 |
---|
287 | | - | SECTION 1.(j) G.S. 90-91(k)16. reads as rewritten: 32 |
---|
288 | | - | "16. Mesterolene,Mesterolone," 33 |
---|
289 | | - | SECTION 2. This act is effective when it becomes law. 34 |
---|
| 177 | + | n. Indazole carboxaldehydes. Any compound structurally derived from 26 |
---|
| 178 | + | 1H-indazole-3-carboxaldehyde or 1H-indazole-2-carboxaldehyde 27 |
---|
| 179 | + | substituted in both of the following ways: 28 |
---|
| 180 | + | … 29 |
---|
| 181 | + | 2. At the carbon of the carboxaldehyde by a phenyl, benzyl, 30 |
---|
| 182 | + | naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 31 |
---|
| 183 | + | whether or not the compound is further modified to any extent 32 |
---|
| 184 | + | in the following ways: (i) substitution to the indazole ring to 33 |
---|
| 185 | + | any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 34 |
---|
| 186 | + | adamantyl, cyclopropyl, or propionaldehyde group to any 35 |
---|
| 187 | + | extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 36 |
---|
| 188 | + | or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 37 |
---|
| 189 | + | naphthyl, adamantyl, or cyclopropyl ring. 38 |
---|
| 190 | + | o. Indazole carboxamides. Any compound structurally derived from 39 |
---|
| 191 | + | 1H-indazole-3-carboxamide or 1H -indazole-2-carboxamide 40 |
---|
| 192 | + | substituted in one or both of the following ways: 41 |
---|
| 193 | + | 1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 42 |
---|
| 194 | + | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 43 |
---|
| 195 | + | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 44 |
---|
| 196 | + | 1-(N-methyl-2-pyrrolidinyl)methyl, 45 |
---|
| 197 | + | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 46 |
---|
| 198 | + | benzyl, or halo benzyl group; andor 47 |
---|
| 199 | + | 2. At the nitrogen of the carboxamide by a phenyl, benzyl, 48 |
---|
| 200 | + | naphthyl, adamantyl, cyclopropyl, or propionaldehyde 49 |
---|
| 201 | + | group;group, or methyl 3,3-dimethyl-butanoate group; 50 General Assembly Of North Carolina Session 2025 |
---|
| 202 | + | House Bill 330-First Edition Page 5 |
---|
| 203 | + | whether or not the compound is further modified to any extent 1 |
---|
| 204 | + | in the following ways: (i) substitution to the indazole ring to 2 |
---|
| 205 | + | any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 3 |
---|
| 206 | + | adamantyl, cyclopropyl, or propionaldehyde group to any 4 |
---|
| 207 | + | extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 5 |
---|
| 208 | + | or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 6 |
---|
| 209 | + | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 7 |
---|
| 210 | + | class include, but are not limited to: AKB-48, fluoro-AKB-48, 8 |
---|
| 211 | + | APINCACA, AB-PINACA, AB -FUBINACA, 9 |
---|
| 212 | + | ADB-FUBINACA, and ADB-PINACA.ADB-PINACA, 10 |
---|
| 213 | + | ADB-INACA, MDMB-INACA, MDMB-5Me-INACA, and 11 |
---|
| 214 | + | MDMB-5Br-INACA. 12 |
---|
| 215 | + | … 13 |
---|
| 216 | + | s. Oxindoles. Any compound structurally derived from 14 |
---|
| 217 | + | 3-hydrazonoindolin-2-one substituted in one or both of the following 15 |
---|
| 218 | + | ways: 16 |
---|
| 219 | + | 1. At the nitrogen atom of the oxoindole ring by an alkyl, 17 |
---|
| 220 | + | haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, 18 |
---|
| 221 | + | cycloalkylethyl; or 19 |
---|
| 222 | + | 2. At the nitrogen of the hydrazide by a phenyl, benzyl, naphthyl, 20 |
---|
| 223 | + | adamantyl, cyclopropyl, or propionaldehyde group; 21 |
---|
| 224 | + | whether or not the compound is further modified to any extent 22 |
---|
| 225 | + | in the following ways: (i) substitution to the oxoindole ring to 23 |
---|
| 226 | + | any extent or (ii) substitution to the phenyl, benzyl, naphthyl, 24 |
---|
| 227 | + | adamantyl, cyclopropyl, or propionaldehyde group to any 25 |
---|
| 228 | + | extent. Substances in this class include, but are not limited to: 26 |
---|
| 229 | + | BZO-POXIZID, BZO-HEXOXIZIDE, 5F-BZO-POXIZIDE. 27 |
---|
| 230 | + | t. Indole acetamides. Any compound structurally derived from 28 |
---|
| 231 | + | 1H-indole-3-acetamide or 1H-indole-2-acetamide substituted in one or 29 |
---|
| 232 | + | both of the following ways: 30 |
---|
| 233 | + | 1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 31 |
---|
| 234 | + | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 32 |
---|
| 235 | + | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 33 |
---|
| 236 | + | 1-(N-methyl-2-pyrrolidinyl)methyl, 34 |
---|
| 237 | + | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 35 |
---|
| 238 | + | benzyl, or halo benzyl group; or 36 |
---|
| 239 | + | 2. At the nitrogen of the acetamide by a phenyl, benzyl, naphthyl, 37 |
---|
| 240 | + | adamantyl, cyclopropyl, or propionaldehyde group; 38 |
---|
| 241 | + | whether or not the compound is further modified to any extent 39 |
---|
| 242 | + | in the following ways: (i) substitution to the indole ring to any 40 |
---|
| 243 | + | extent, (ii) substitution to the phenyl, benzyl, naphthyl, 41 |
---|
| 244 | + | adamantyl, cyclopropyl, or propionaldehyde group to any 42 |
---|
| 245 | + | extent, (iii) a nitrogen heterocyclic analog of the indole ring, or 43 |
---|
| 246 | + | (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 44 |
---|
| 247 | + | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 45 |
---|
| 248 | + | class include, but are not limited to: AFUBIATA, CH-PIATA, 46 |
---|
| 249 | + | AB-CHMIATA, ADB-FUBIATA. 47 |
---|
| 250 | + | u. Indazole acetaldehydes. Any compound structurally derived from 48 |
---|
| 251 | + | 1H-indazol-3-ylacetaldehyde or 1H -indazol-2-ylacetaldehyde 49 |
---|
| 252 | + | substituted in one or both of the following ways: 50 General Assembly Of North Carolina Session 2025 |
---|
| 253 | + | Page 6 House Bill 330-First Edition |
---|
| 254 | + | 1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 1 |
---|
| 255 | + | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 2 |
---|
| 256 | + | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 3 |
---|
| 257 | + | 1-(N-methyl-2-pyrrolidinyl)methyl, 4 |
---|
| 258 | + | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 5 |
---|
| 259 | + | benzyl, or halo benzyl group; or 6 |
---|
| 260 | + | 2. At the nitrogen of the carboxamide by a phenyl, benzyl, 7 |
---|
| 261 | + | naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 8 |
---|
| 262 | + | whether or not the compound is further modified to any extent 9 |
---|
| 263 | + | in the following ways: (i) substitution to the indazole ring to 10 |
---|
| 264 | + | any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 11 |
---|
| 265 | + | adamantyl, cyclopropyl, or propionaldehyde group to any 12 |
---|
| 266 | + | extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 13 |
---|
| 267 | + | or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 14 |
---|
| 268 | + | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 15 |
---|
| 269 | + | class include, but are not limited to: ADB-BUTINAATA, 16 |
---|
| 270 | + | ADB-FUBINAATA. 17 |
---|
| 271 | + | v. Pyrazoles. Any compound structurally derived from 1H-pyrazole 18 |
---|
| 272 | + | substituted in all of the following ways: 19 |
---|
| 273 | + | 1. At the 1 position of the pyrazole ring by an alkyl, haloalkyl, or 20 |
---|
| 274 | + | alkenyl group. 21 |
---|
| 275 | + | 2. At the 3 position of the pyrazole ring by a halo benzyl or 22 |
---|
| 276 | + | propionaldehyde group. 23 |
---|
| 277 | + | 3. At the 5 position of the pyrazole ring by a halo benzyl or 24 |
---|
| 278 | + | propionaldehyde group; 25 |
---|
| 279 | + | whether or not the compound is further modified by a 26 |
---|
| 280 | + | substitution to the propionaldehyde group to any extent. 27 |
---|
| 281 | + | Substances in this class include, but are not limited to: 28 |
---|
| 282 | + | 3,5-ADB-4en-PFUPPYCA, 5-fluoro-3,5-AB-PFUPPYCA." 29 |
---|
| 283 | + | SECTION 1.(h) G.S. 90-90(2)h1. reads as rewritten: 30 |
---|
| 284 | + | "h1. Fentanyl immediate precursor chemical, 31 |
---|
| 285 | + | 4-anilino-N-phenethyl-4-piperidine 32 |
---|
| 286 | + | (ANPP).4-anilino-N-phenethylpiperdine (ANPP)." 33 |
---|
| 287 | + | SECTION 1.(i) G.S. 90-91(k)11. reads as rewritten: 34 |
---|
| 288 | + | "11. Dehydrochlormethyltestosterone,Dehydrochloromethyltestosterone," 35 |
---|
| 289 | + | SECTION 1.(j) G.S. 90-91(k)16. reads as rewritten: 36 |
---|
| 290 | + | "16. Mesterolene,Mesterolone," 37 |
---|
| 291 | + | SECTION 2. This act is effective when it becomes law. 38 |
---|